Trinity Biotech | TRIB - Passivo Circulante





Passivo Circulante Alterar Data
Abbott USD 18.38B 1.88B 2026-03
Bayer EUR 33.46B 875M 2026-03
Bio-Rad Laboratories USD 961.3M 44.3M 2026-06
EDAP TMS EUR 37.51M 6.1M 2026-03
J&J USD 54.9B 2.82B 2026-06
Mesa Laboratories USD 54.4M 6.1M 2025-12
OraSure Technologies USD 44.08M 4.29M 2026-03
Plus Therapeutics USD 7.96M 4.36M 2026-03
Roche Holding CHF 28.85B 846M 2026-06
Siemens EUR 49.52B 168M 2026-03
Thermo Fisher Scientific USD 15.07B 448M 2026-06
Tosoh JPY 391.91B 37.39B 2026-06
Trinity Biotech USD 141.21M 106.72M 2025-12
Veracyte USD 62.74M 6.62M 2026-06